HomeBIOR • OTCMKTS
add
Biora Therapeutics Inc
Previous close
$0.59
Day range
$0.45 - $0.60
Year range
$0.26 - $19.90
Market cap
2.69M USD
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Revenue | 32.00K | — |
Operating expense | 16.26M | -30.28% |
Net income | -18.40M | 74.95% |
Net profit margin | -57.51K | — |
Earnings per share | — | — |
EBITDA | -16.12M | 30.52% |
Effective tax rate | 0.20% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 3.20M | -74.57% |
Total assets | 14.50M | -58.20% |
Total liabilities | 121.13M | -21.08% |
Total equity | -106.63M | — |
Shares outstanding | 4.52M | — |
Price to book | -0.02 | — |
Return on assets | -247.60% | — |
Return on capital | 75.89% | — |
Cash Flow
Net change in cash
(USD) | Sep 2024info | Y/Y change |
---|---|---|
Net income | -18.40M | 74.95% |
Cash from operations | -8.73M | 20.88% |
Cash from investing | -19.00K | -1,800.00% |
Cash from financing | 6.62M | 332.44% |
Net change in cash | -2.13M | 84.66% |
Free cash flow | 30.97M | 11.13% |
About
Founded
2010
Headquarters
Website
Employees
58